COVID-19 Impact on Global Acne Vulgaris Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Acne Vulgaris Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 CB-0601
  • 1.4.3 CJM-112
  • 1.4.4 CLS-007
  • 1.4.5 Dapsone
  • 1.4.6 DFD-10
  • 1.4.7 DLX-2323
  • 1.4.8 Others
• 1.5 Market by Application
  • 1.5.1 Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Clinic
  • 1.5.3 Hospital
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Acne Vulgaris Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Acne Vulgaris Treatment Industry
    • 1.6.1.1 Acne Vulgaris Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Acne Vulgaris Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Acne Vulgaris Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Acne Vulgaris Treatment Market Perspective (2015-2026)
• 2.2 Acne Vulgaris Treatment Growth Trends by Regions
  • 2.2.1 Acne Vulgaris Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Acne Vulgaris Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Acne Vulgaris Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Acne Vulgaris Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Acne Vulgaris Treatment Players by Market Size
  • 3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Acne Vulgaris Treatment Market Concentration Ratio
  • 3.2.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2019
• 3.3 Acne Vulgaris Treatment Key Players Head office and Area Served
• 3.4 Key Players Acne Vulgaris Treatment Product Solution and Service
• 3.5 Date of Enter into Acne Vulgaris Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2021-2026)

5 Acne Vulgaris Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Acne Vulgaris Treatment Market Size by Application (2015-2020)
• 5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Acne Vulgaris Treatment Market Size (2015-2020)
• 6.2 Acne Vulgaris Treatment Key Players in North America (2019-2020)
• 6.3 North America Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 6.4 North America Acne Vulgaris Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Acne Vulgaris Treatment Market Size (2015-2020)
• 7.2 Acne Vulgaris Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 7.4 Europe Acne Vulgaris Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Acne Vulgaris Treatment Market Size (2015-2020)
• 8.2 Acne Vulgaris Treatment Key Players in China (2019-2020)
• 8.3 China Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 8.4 China Acne Vulgaris Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Acne Vulgaris Treatment Market Size (2015-2020)
• 9.2 Acne Vulgaris Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 9.4 Japan Acne Vulgaris Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Acne Vulgaris Treatment Market Size (2015-2020)
• 10.2 Acne Vulgaris Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Acne Vulgaris Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Acne Vulgaris Treatment Market Size (2015-2020)
• 11.2 Acne Vulgaris Treatment Key Players in India (2019-2020)
• 11.3 India Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 11.4 India Acne Vulgaris Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Acne Vulgaris Treatment Market Size (2015-2020)
• 12.2 Acne Vulgaris Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Acne Vulgaris Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Acne Vulgaris Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Common Pharma Inc
  • 13.1.1 Common Pharma Inc Company Details
  • 13.1.2 Common Pharma Inc Business Overview and Its Total Revenue
  • 13.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
  • 13.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2015-2020))
  • 13.1.5 Common Pharma Inc Recent Development
• 13.2 Cutanea Life Sciences Inc
  • 13.2.1 Cutanea Life Sciences Inc Company Details
  • 13.2.2 Cutanea Life Sciences Inc Business Overview and Its Total Revenue
  • 13.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
  • 13.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.2.5 Cutanea Life Sciences Inc Recent Development
• 13.3 Dermira Inc
  • 13.3.1 Dermira Inc Company Details
  • 13.3.2 Dermira Inc Business Overview and Its Total Revenue
  • 13.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
  • 13.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.3.5 Dermira Inc Recent Development
• 13.4 ELORAC Inc
  • 13.4.1 ELORAC Inc Company Details
  • 13.4.2 ELORAC Inc Business Overview and Its Total Revenue
  • 13.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
  • 13.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.4.5 ELORAC Inc Recent Development
• 13.5 Ensol Biosciences Inc
  • 13.5.1 Ensol Biosciences Inc Company Details
  • 13.5.2 Ensol Biosciences Inc Business Overview and Its Total Revenue
  • 13.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
  • 13.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.5.5 Ensol Biosciences Inc Recent Development
• 13.6 Foamix Pharmaceuticals Ltd
  • 13.6.1 Foamix Pharmaceuticals Ltd Company Details
  • 13.6.2 Foamix Pharmaceuticals Ltd Business Overview and Its Total Revenue
  • 13.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
  • 13.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.6.5 Foamix Pharmaceuticals Ltd Recent Development
• 13.7 Galderma SA
  • 13.7.1 Galderma SA Company Details
  • 13.7.2 Galderma SA Business Overview and Its Total Revenue
  • 13.7.3 Galderma SA Acne Vulgaris Treatment Introduction
  • 13.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.7.5 Galderma SA Recent Development
• 13.8 GlaxoSmithKline Plc
  • 13.8.1 GlaxoSmithKline Plc Company Details
  • 13.8.2 GlaxoSmithKline Plc Business Overview and Its Total Revenue
  • 13.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
  • 13.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.8.5 GlaxoSmithKline Plc Recent Development
• 13.9 Helix BioMedix Inc
  • 13.9.1 Helix BioMedix Inc Company Details
  • 13.9.2 Helix BioMedix Inc Business Overview and Its Total Revenue
  • 13.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
  • 13.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.9.5 Helix BioMedix Inc Recent Development
• 13.10 Hovione FarmaCiencia SA
  • 13.10.1 Hovione FarmaCiencia SA Company Details
  • 13.10.2 Hovione FarmaCiencia SA Business Overview and Its Total Revenue
  • 13.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
  • 13.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 13.10.5 Hovione FarmaCiencia SA Recent Development
• 13.11 Lee's Pharmaceutical Holdings Ltd
  • 10.11.1 Lee's Pharmaceutical Holdings Ltd Company Details
  • 10.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview and Its Total Revenue
  • 10.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
  • 10.11.4 Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.11.5 Lee's Pharmaceutical Holdings Ltd Recent Development
• 13.12 LEO Pharma A/S
  • 10.12.1 LEO Pharma A/S Company Details
  • 10.12.2 LEO Pharma A/S Business Overview and Its Total Revenue
  • 10.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
  • 10.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.12.5 LEO Pharma A/S Recent Development
• 13.13 Novabiotics Ltd
  • 10.13.1 Novabiotics Ltd Company Details
  • 10.13.2 Novabiotics Ltd Business Overview and Its Total Revenue
  • 10.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
  • 10.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.13.5 Novabiotics Ltd Recent Development
• 13.14 Novan Inc
  • 10.14.1 Novan Inc Company Details
  • 10.14.2 Novan Inc Business Overview and Its Total Revenue
  • 10.14.3 Novan Inc Acne Vulgaris Treatment Introduction
  • 10.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.14.5 Novan Inc Recent Development
• 13.15 Novartis AG
  • 10.15.1 Novartis AG Company Details
  • 10.15.2 Novartis AG Business Overview and Its Total Revenue
  • 10.15.3 Novartis AG Acne Vulgaris Treatment Introduction
  • 10.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.15.5 Novartis AG Recent Development
• 13.16 Paratek Pharmaceuticals Inc
  • 10.16.1 Paratek Pharmaceuticals Inc Company Details
  • 10.16.2 Paratek Pharmaceuticals Inc Business Overview and Its Total Revenue
  • 10.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
  • 10.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.16.5 Paratek Pharmaceuticals Inc Recent Development
• 13.17 Pfizer Inc
  • 10.17.1 Pfizer Inc Company Details
  • 10.17.2 Pfizer Inc Business Overview and Its Total Revenue
  • 10.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
  • 10.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.17.5 Pfizer Inc Recent Development
• 13.18 Phosphagenics Ltd
  • 10.18.1 Phosphagenics Ltd Company Details
  • 10.18.2 Phosphagenics Ltd Business Overview and Its Total Revenue
  • 10.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
  • 10.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2015-2020)
  • 10.18.5 Phosphagenics Ltd Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer